Holen Sie sich die Stockscreener-App
85.12
0.72%
0.61
Handel nachbörslich:
84.62
-0.50
-0.59%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Astrazeneca PLC Aktie (AZN) Neueste Nachrichten
AstraZeneca cuts US drug pricing deal; FDA declares Novo plant out of compliance - BioPharma Dive
AstraZeneca opens expanded facility in Texas - breakingthenews.net
AstraZeneca’s US listing plan backed by key shareholder advisers - The Times
Is AstraZeneca PLC Depositary Receipt stock ready for a breakoutMarket Sentiment Report & Daily Stock Trend Reports - newser.com
AstraZeneca reaches agreement with US government to reduce drug prices - Investing.com
Will breakout in AstraZeneca PLC Depositary Receipt lead to full recovery2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
AstraZeneca reaches agreement with US government to reduce drug prices By Investing.com - Investing.com South Africa
Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN) - The Globe and Mail
UBS Keeps Their Buy Rating on AstraZeneca (AZN) - The Globe and Mail
Advanced analytics toolkit walkthrough for AstraZeneca PLC Depositary ReceiptJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com
Barclays Says AstraZeneca's US Drug Pricing Deal 'Strategically Constructive' - 富途牛牛
Astrazeneca to lower US prices amid Trump squeeze - MarketScreener
Trump Strikes Again: AstraZeneca's Surprise Drug Deal Could Shake Big Pharma's Global Pricing Power - Yahoo
AZN Strikes Drug Pricing Deal With Trump, Gets 3-Year Tariff Reprieve - The Globe and Mail
Why AstraZeneca PLC Depositary Receipt stock remains undervaluedWeekly Stock Recap & Target Return Focused Picks - newser.com
How to monitor AstraZeneca PLC Depositary Receipt with trend dashboardsMarket Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Global markets live: Blackstone, Pfizer, Tesla, Stellantis, AstraZeneca… - MarketScreener
Will AstraZeneca PLC Depositary Receipt bounce back from current supportJuly 2025 Earnings & Real-Time Sentiment Analysis - newser.com
AstraZeneca (AZN) Agrees to Lower Drug Prices in the U.S. with S - GuruFocus
AstraZeneca's drug pricing deal with Trump far from clear result, say analysts - Proactive financial news
AstraZeneca inks Trump drug pricing deal amid tariff threats - Pharmaceutical Technology
AstraZeneca PLC (AZN) Stock Analysis: 6.2% Potential Upside Fuels Investor Interest - DirectorsTalk Interviews
AstraZeneca: Drug Pricing Agreement Mitigates Threats of Tariffs and Price Controls - Morningstar Canada
Vanguard Personalized Indexing Management LLC Increases Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Trending tickers: TSMC, AstraZeneca, Lloyds, Fresnillo and Canal+ - Yahoo
AstraZeneca confirms deal with US government on drug prices - MarketScreener
AstraZeneca reaches agreement with Trump to lower its prices in the US - MarketScreener
AstraZeneca agrees to offer US discounts in exchange for no tariffs - Proactive financial news
AstraZeneca to cut US drug prices in key White House deal - Sharecast.com
AstraZeneca : Agreement with US Govt to lower medicine prices - MarketScreener
Trump announces deal with AstraZeneca on drug prices, tariffs - MarketScreener
AstraZeneca Plc Reaches Agreement With Trump Administration To Cut US Drug Prices - DirectorsTalk Interviews
AstraZeneca Joins US President Trump's Drug-Cost Initiative, Secures Tariff Reprieve - MarketScreener
US FDA Commissioner’s Involvement In AstraZeneca Pricing Deal Raises Ethical, Legal Questions - insights.citeline.com
President Trump announces deal with AstraZeneca on drug prices and tariffs - Taipei Times
Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump - MarketScreener
AstraZeneca PLC $AZN Shares Bought by Aberdeen Group plc - MarketBeat
AstraZeneca PLC $AZN Stock Holdings Lowered by US Bancorp DE - MarketBeat
AstraZeneca Signs US Drug Pricing Deal, Secures Three-year Delay to Tariffs - MarketScreener
Target Identification and Validation In Drug Discovery - Oncodaily
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts - ts2.tech
Benson Investment Management Company Inc. Takes $4.44 Million Position in AstraZeneca PLC $AZN - MarketBeat
Mengis Capital Management Inc. Grows Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Acquired by Ramirez Asset Management Inc. - MarketBeat
AstraZeneca PLC $AZN Stock Holdings Lowered by Blair William & Co. IL - MarketBeat
Callan Family Office LLC Has $3.90 Million Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Trump announces deal with AstraZeneca to cut drug prices across US - Hindustan Times
AstraZeneca agrees to MFN price reductions with US government - European Biotechnology Magazine
AstraZeneca | Pharmaceuticals, Vaccines, & Facts | Britannica Money - Britannica
AstraZeneca Strikes 'Most Favored Nation' Price Deal - Law360
AstraZeneca (AZN) Reaches Agreement with White House to Lower Dr - GuruFocus
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal - MarketScreener
AstraZeneca Agrees To Lower Drug Prices For Medicaid Under Trump Administration Deal - Barchart.com
AstraZeneca CEO says company granted three-year tariff exemption - MarketScreener
AstraZeneca : announces historic agreement with US Government to lower the cost of medicines for American patients - MarketScreener
Trump Announces AstraZeneca Drug Price Cuts for Tariff Reprieve - Bloomberg.com
Trump says AstraZeneca to offer drugs to US at discounted prices - Reuters
AstraZeneca (AZN) to Slash Drug Prices in New Deal - GuruFocus
Trump strikes drug-pricing deal with AstraZenecaMSNBC - MarketScreener
AstraZeneca’s stock is climbing after hours following a deal with the Trump White House - MarketWatch
AstraZeneca set to announce drug price deal with Trump administrationBloomberg By Investing.com - Investing.com South Africa
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):